drugset / Trial / NCT04278131
BS01 in Patients With Retinitis Pigmentosa
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAG-ChronosFP) in Patients with Retinitis Pigmentosa
Timeline
- Start
- 2020-02-06
- Primary completion
- 2026-12-30
- Completion
- 2029-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BS01 | Gene therapy (AAV / viral vector) | — | — |